Drug Type Small molecule drug |
Synonyms CX 13 608, CX-13-608 |
Target |
Mechanism Proteasome inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Relapse multiple myeloma | Phase 2 | CN | 03 Jun 2021 |